Clinical Trial Update: An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating an evidence-based protocol for oxytocin administration in vaginal delivery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage
• Uterine Atony

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: NYU Langone Health | Conditions: Uterine Atony, Postpartum Hemorrhage | Phase 4 | Status: WITHDRAWN